Could Depo-Provera Have Contributed to My Meningioma? Here's What to Know

This article has been reviewed for accuracy by the team of writers and legal experts at James Rolshouse Law Firm PLLC. It should not be taken as legal advice from an attorney.

Women who have been diagnosed with meningioma are correct to wonder if their birth control may have played a role. Depo-Provera, the injectable contraceptive, has recently been linked in studies to benign meningioma in cases involving long-term use. Research indicates that the synthetic hormone in Depo-Provera, medroxyprogesterone acetate, could influence tumor growth due to its interaction with progesterone receptors commonly found in meningiomas.

Depo-Provera contraceptive injection (Medroxyprogesterone Acetate) in a single-dose vial, held by gloved hands with a syringe.

This connection has prompted growing concern among healthcare providers and patients, particularly those who have relied on Depo-Provera for extended periods. In this article, we'll explore the emerging research, what it means for women diagnosed with benign meningioma, and how to navigate your legal options moving forward.

What Exactly Is Meningioma?

Meningioma is a type of tumor that forms in the meninges, the protective layers of tissue surrounding the brain and spinal cord. Although most meningiomas are benign (non-cancerous), their location can cause significant symptoms—including neurological symptoms—such as:

  • Headaches: Frequent or persistent headaches, often worse in the morning and increasing in severity over time.
  • Speech difficulties: Trouble speaking clearly or finding the right words.
  • Vision problems: Difficulty seeing clearly, including blurred vision or double vision.
  • Memory issues: Challenges with recalling recent events or noticeable memory lapses.
  • Hearing Loss: Unexpected hearing problems, such as partial loss or ringing in the ears.
  • Weakness or numbness: Loss of strength or sensation, particularly in the arms or legs.
  • Loss of smell: A sudden inability to detect scents, which can sometimes occur with meningiomas.
  • Seizures: The sudden onset of seizures without a known cause, which may indicate the presence of a tumor.

Meningioma brain tumors are more common in women than men, suggesting a possible hormonal influence on their development. Estrogen and progesterone receptors are often found in these tumors, which has led researchers to investigate the role of hormonal therapies, like Depo-Provera, in their growth.

Depo-Provera and Meningioma: The Connection

The use of Depo-Provera may lead to an increased risk of developing meningiomas. This link is thought to stem from the medication's synthetic progestin (medroxyprogesterone acetate), which mimics the effects of natural progesterone in the body. Since many meningiomas contain progesterone receptors, exposure to high levels of this hormone over time could potentially stimulate tumor growth.

New research findings

A pivotal case-control study published in The BMJ in 2024 looked at the possible connection between certain contraceptives, including Depo-Provera, and the risk of developing meningiomas. Researchers reviewed medical records of over 18,000 women in France who had brain surgery for meningiomas between 2009 and 2018, comparing them with a group of 90,000 women who didn't have the condition.

The study found that women who used contraceptives containing medroxyprogesterone acetate (MPA), the active ingredient in Depo-Provera, had a much higher risk—up to 5.6 times greater—of developing intracranial meningiomas. The longer a woman used this type of contraceptive, the higher her risk, according to the research.

It's important to note that while this study highlights a potential connection, it does not prove causation. Factors such as individual medical history, genetic predisposition, and other environmental influences may also contribute to meningioma risk.

Regardless, if you or someone you care about developed a meningioma after using Depo-Provera, this research could help support your claim for legal action.

What Does This Mean for Women Diagnosed with Meningioma?

If you've been diagnosed with meningioma and have a history of using Depo-Provera, it's worth discussing this potential link with your healthcare provider. While the connection between Depo-Provera and meningioma remains under investigation, understanding your medication history could provide valuable insights into your diagnosis.

Most meningiomas are benign and slow-growing, but their location can still cause significant symptoms and the potential need for surgical removal or radiation therapy. These treatment options can effectively manage the condition, though they may carry some risks, such as temporary side effects or recovery time.

Steps to take if you think Depo Provera may be related to your meningioma:

  1. Review your medical history: Gather information about your Depo-Provera use, including how long you've been on the medication and at what dosage.
  2. Consult your doctor: Share your concerns with your healthcare provider and discuss whether hormonal therapies, genetics, or other factors might have influenced your condition.
  3. Explore legal options: If you suspect a link between your brain tumor diagnosis and Depo-Provera use, consult an attorney. At James Rolshouse Law Firm PLLC, we can help determine if you qualify for compensation with a quick assessment.

Depo-Provera Meningioma Lawsuits

In recent years, more and more lawsuits have been filed against Pfizer, the manufacturers of Depo-Provera, alleging that the drug contributed to the development of meningiomas in some women. These lawsuits often claim that the risks were not adequately disclosed to patients or healthcare providers.

Key considerations for legal action:

  • Proof of use: Documentation showing your history of Depo-Provera use.
  • Medical records: Evidence of your meningioma diagnosis and related treatments.

Compensation: What you may be entitled to

Women who have developed meningiomas after using Depo-Provera may be eligible for financial compensation. Potential damages include:

  • Medical expenses: Reimbursement for past and future costs related to diagnosis, treatment, surgeries, and ongoing care.
  • Lost wages: Compensation for income lost due to missed work or inability to return to employment.
  • Pain and suffering: Damages for physical and emotional distress caused by the illness and treatments.
  • Loss of quality of life: Compensation for the long-term impact on daily life, such as reduced mobility or cognitive function.

Depo Provera lawsuits not only provide justice to those affected, but they also help cover the financial strain caused by a meningioma diagnosis and the subsequent treatment needed.

At James Rolshouse Law Firm PLLC, our attorneys are committed to helping you seek justice and hold pharmaceutical companies accountable. We provide compassionate, expert guidance tailored to your unique case.

If you have been a long-term Depo-Provera user and developed a meningioma brain tumor, you may be eligible for compensation. Take a quick assessment to find out if you qualify. James Rolshouse Law Firm PLLC is here to fight for the compensation you deserve.

This article contains Attorney Advertising. Images used feature models for illustrative purposes only and do not depict actual clients or individuals associated with this service or affected by these products.